Gemcitabine and oxaliplatin in the treatment of patients with immunotherapy‐resistant advanced renal cell carcinomaCamillo Porta, Alberto Riccardi, Andrea Sartore‐Bianchi et al.|Cancer|2004Cited by 23
869 Gemcitabine (GEM) and oxaliplatin (I-OHP) to treat immunotherapy-resistant advanced renal cell carcinoma (ARCC) patients (pts.): preliminary results of a single institution phase II studyCamillo Porta, Alberto Riccardi, Chiara Paglino et al.|European Journal of Cancer Supplements|2003Cited by 0